Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Knight Therapeutics (TSE:GUD)
TSX:GUD
RESEARCH TOOLSreports
Knight Therapeutics (GUD) Ownership - Who Owns Knight Therapeutics?
81 Followers
Knight Therapeutics (GUD) Ownership Overview
88.06% Insiders
1.94% Mutual Funds
0.84% Other Institutional Investors
9.17% Public Companies and
Individual Investors
The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail and individual investors. Approximately 2.77% of the company’s stock is owned by Institutional Investors, 88.06% is owned by Insiders and 9.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 14, 2024 | Robert Nathaniel Lande Non Executive,director | Sold | C$118710 |
| Jun 06, 2024 | Jonathan Ross Goodman Chairman, >10% Owner | Bought | C$29000 |
| May 30, 2024 | Robert Nathaniel Lande Non Executive,director | Sold | C$147600 |
| May 11, 2024 | Sime Armoyan Shareholder, >10% Owner | Sold | C$440895 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,763,600 | Insider | 21.47% | 125,140,700 | |
| 21,723,933 | Insider | 21.43% | 124,912,615 | |
| 21,685,133 | Insider | 21.39% | 124,689,515 | |
| 12,666,200 | Insider | 12.49% | 72,830,650 | |
| 10,424,884 | Insider | 10.28% | 59,943,083 | |
| 1,178,761 | Institution | 1.16% | 4,970,835 | |
| 411,025 | Institution | 0.41% | 1,733,292 | |
| 337,512 | Institution | 0.33% | 1,423,288 | |
| 288,308 | Institution | 0.28% | 1,215,795 | |
| 269,951 | Institution | 0.27% | 1,138,383 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,178,761 | Institution | 1.16% | 4,970,835 | |
| 411,025 | Institution | 0.41% | 1,733,292 | |
| 269,951 | Institution | 0.27% | 1,138,383 | |
| 44,174 | Institution | 0.04% | 186,282 | |
| 26,600 | Institution | 0.03% | 112,172 | |
| 22,318 | Institution | 0.02% | 94,115 | |
| 5,400 | Institution | <0.01% | 22,772 | |
| 3,700 | Institution | <0.01% | 15,603 | |
| 2,400 | Institution | <0.01% | 10,121 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 111,926 | Institution | 0.11% | 467,499 | |
| 108,965 | Institution | 0.11% | 455,914 | |
| 70,233 | Institution | 0.07% | 293,353 | |
| 65,016 | Institution | 0.06% | 271,563 | |
| 62,333 | Institution | 0.06% | 260,356 | |
| 43,856 | Institution | 0.04% | 250,856 | |
| 49,033 | Institution | 0.05% | 204,804 | |
| 21,345 | Institution | 0.02% | 110,781 | |
| 22,855 | Institution | 0.02% | 95,462 | |
| 20,346 | Institution | 0.02% | 85,128 |
FAQ
Who Owns Knight Therapeutics (TSE:GUD)?
According to the latest TipRanks data, approximately 0.84% of the company's stock is held by institutional investors, 88.06% is held by insiders, and 9.17% is held by retail investors.
What percentage of Knight Therapeutics (TSE:GUD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.84% of Knight Therapeutics (TSE:GUD) stock is held by institutional investors.
What percentage of Knight Therapeutics (TSE:GUD) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.17% of Knight Therapeutics (TSE:GUD) stock is held by retail investors.
Who owns the most shares of Knight Therapeutics (TSE:GUD)?
Jonathan Ross Goodman owns the most shares of Knight Therapeutics (TSE:GUD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.